Login
Login

APHRC Online Microdata Library
  • Home
  • About APHRC
  • Datasets
  • Collections
  • Citations
  • Resources
  • How to use it?
  • Why sharing data?
  • Contact us
    Home / Central Data Catalog / HEALTH_AND_WELL-BEING / DDI-KEN-APHRC-GEGO-2021-V1.0 / variable [V111]
Health_and_Well-Being

Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya, GECO-Kenya

Kenya, , 2021 - 2023
Health and Well-Being (HaW)
Gershim Asiki,MD,Phd
Last modified November 26, 2024 Page views 39271 Documentation in PDF Metadata DDI/XML JSON
  • Study description
  • Documentation
  • Data Description
  • Get Microdata
  • Data files
  • GECO_FinalData1
CSV JSON

3.6c ii: If the reply is (c) ( Both insulin + Oral Hypoglycaemic drug) please in (q3p6c_ii)

Data file: GECO_FinalData1

Overview

vald 7
invd 0
Interval discrete

Questions and instructions

Literal question
Which medication your doctor prescribed for the treatment and care of diabetes in the [COVID] period?
Je, daktari wako alikuagizia dawa gani kwa ajili ya matibabu na utunzaji wa ugonjwa wa sukari katika kipindi cha COVID?
Categories
Value Category
Glucomet 500mg,nogluc
Insulin, Glucomet
Mixtard Glucophage
Mixtard and glocophage
NA
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Question pretext
Medications
Has this changed in [COVID] period = the time you were most affected [if applicable]
Question post text
N/A
Interviewer instructions
N/A

Description

Text
The question was asked to patients with type 2 diabetes about the type of medication their doctor prescribed for the treatment and care of their diabetes during the COVID-19 pandemic.
Universe
Patients with type 2 diabetes

others

Notes
"3.6c ii: If the reply is (c) ( Both insulin + Oral Hypoglycaemic drug) please insert name of drug below"
APHRC Microdata Portal

© APHRC Microdata Portal, All Rights Reserved. Slot Online